These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 16899828
1. Can global initiative for Chronic Obstructive Lung Disease stage 0 provide prognostic information on long-term mortality in men? Stavem K, Sandvik L, Erikssen J. Chest; 2006 Aug; 130(2):318-25. PubMed ID: 16899828 [Abstract] [Full Text] [Related]
2. Association between all-cause and cause-specific mortality and the GOLD stages 1-4: A 30-year follow-up among Finnish adults. Mattila T, Vasankari T, Kanervisto M, Laitinen T, Impivaara O, Rissanen H, Knekt P, Jousilahti P, Saarelainen S, Puukka P, Heliövaara M. Respir Med; 2015 Aug; 109(8):1012-8. PubMed ID: 26108990 [Abstract] [Full Text] [Related]
4. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Löfdahl CG. Respir Res; 2005 Aug 25; 6(1):98. PubMed ID: 16120227 [Abstract] [Full Text] [Related]
5. Breathlessness, phlegm and mortality: 26 years of follow-up in healthy middle-aged Norwegian men. Stavem K, Sandvik L, Erikssen J. J Intern Med; 2006 Oct 25; 260(4):332-42. PubMed ID: 16961670 [Abstract] [Full Text] [Related]
10. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. Soriano JB, Lamprecht B, Ramírez AS, Martinez-Camblor P, Kaiser B, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluña JJ, de-Torres JP, Miravitlles M, Celli BR, Marin JM, Puhan MA, Sobradillo P, Lange P, Sternberg AL, Garcia-Aymerich J, Turner AM, Han MK, Langhammer A, Leivseth L, Bakke P, Johannessen A, Roche N, Sin DD. Lancet Respir Med; 2015 Jun 25; 3(6):443-50. PubMed ID: 25995071 [Abstract] [Full Text] [Related]
11. The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD. Flynn RWV, MacDonald TM, Chalmers JD, Schembri S. Respir Res; 2018 Dec 12; 19(1):249. PubMed ID: 30541559 [Abstract] [Full Text] [Related]
12. Lung function decline and outcomes in an adult population. Mannino DM, Reichert MM, Davis KJ. Am J Respir Crit Care Med; 2006 May 01; 173(9):985-90. PubMed ID: 16439715 [Abstract] [Full Text] [Related]
14. The importance of cardiovascular disease for mortality in patients with COPD: a prognostic cohort study. Zhang J, Rutten FH, Cramer MJ, Lammers JW, Zuithoff NP, Hoes AW. Fam Pract; 2011 Oct 01; 28(5):474-81. PubMed ID: 21602286 [Abstract] [Full Text] [Related]
15. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort. Mannino DM, Davis KJ, Kiri VA. Respir Med; 2009 Feb 01; 103(2):224-9. PubMed ID: 18945605 [Abstract] [Full Text] [Related]
16. Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting. Saleh HZ, Mohan K, Shaw M, Al-Rawi O, Elsayed H, Walshaw M, Chalmers JA, Fabri BM. Eur J Cardiothorac Surg; 2012 Jul 01; 42(1):108-13; discussion 113. PubMed ID: 22290913 [Abstract] [Full Text] [Related]
17. Lung function decline and outcomes in an elderly population. Mannino DM, Davis KJ. Thorax; 2006 Jun 01; 61(6):472-7. PubMed ID: 16517577 [Abstract] [Full Text] [Related]
19. Productive cough is an independent risk factor for the development of COPD in former smokers. Yamane T, Hattori N, Kitahara Y, Haruta Y, Sasaki H, Yokoyama A, Kohno N. Respirology; 2010 Feb 01; 15(2):313-8. PubMed ID: 20070589 [Abstract] [Full Text] [Related]
20. Differences in outcomes between GOLD groups in patients with COPD in the TIOSPIR(®) trial. Dusser D, Wise RA, Dahl R, Anzueto A, Carter K, Fowler A, Calverley PM. Int J Chron Obstruct Pulmon Dis; 2016 Feb 01; 11():133-45. PubMed ID: 26855568 [Abstract] [Full Text] [Related] Page: [Next] [New Search]